Dhesy-Thind SK - Search Results

1

Code status communication training in postgraduate oncology programs: a needs assessment.

Levine OH, Dhesy-Thind SK, McConnell MM, Brouwers MC, Mukherjee SD. Levine OH, et al. Among authors: dhesy thind sk. Curr Oncol. 2020 Dec;27(6):e607-e613. doi: 10.3747/co.27.6221. Epub 2020 Dec 1. Curr Oncol. 2020. PMID: 33380876 Free PMC article.

2

Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials.

Farooqi MAM, Malhotra N, Mukherjee SD, Sanger S, Dhesy-Thind SK, Ellis P, Leong DP. Farooqi MAM, et al. Among authors: dhesy thind sk. PLoS One. 2018 Dec 20;13(12):e0209486. doi: 10.1371/journal.pone.0209486. eCollection 2018. PLoS One. 2018. PMID: 30571754 Free PMC article.

3

A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy.

Mackett K, Dhesy-Thind S, Donovan EK, Mukherjee S, Swaminath A, Leong DP, Voruganti S, Sussman J, Wright J, Okawara G, Fraser G, Sagar S, Bordeleau L, Ellis PM, Hirte H, Kavsak PA. Mackett K, et al. Clin Chim Acta. 2019 Aug;495:355-357. doi: 10.1016/j.cca.2019.04.083. Epub 2019 May 2. Clin Chim Acta. 2019. PMID: 31054914 No abstract available.

4

Attitudes and beliefs toward the use of stereotactic body radiotherapy in oligometastatic breast cancer: A commentary on a survey of Canadian Medical Oncologists.

Donovan E, Dhesy-Thind S, Mukherjee S, Kucharczyk M, Swaminath A. Donovan E, et al. Breast J. 2019 Nov;25(6):1222-1224. doi: 10.1111/tbj.13435. Epub 2019 Jul 1. Breast J. 2019. PMID: 31264272

5

Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?

Barron CC, Tyagi NK, Alhussein MM, Mukherjee SD, Ellis PM, Dhesy-Thind S, Leong DP. Barron CC, et al. Oncologist. 2019 Nov;24(11):1405-1409. doi: 10.1634/theoncologist.2019-0263. Epub 2019 Jul 17. Oncologist. 2019. PMID: 31315962 Free PMC article.

6

An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.

Barron CC, Alhussein MM, Kaur U, Cosman TL, Tyagi NK, Brown M, Mukherjee SD, Ellis PM, Dhesy-Thind S, Leong DP. Barron CC, et al. Curr Oncol. 2019 Aug;26(4):240-246. doi: 10.3747/co.26.4631. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548803 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 33704217

8

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I Trial.

Leong DP, Cosman T, Alhussein MM, Kumar Tyagi N, Karampatos S, Barron CC, Wright D, Tandon V, Magloire P, Joseph P, Conen D, Devereaux PJ, Ellis PM, Mukherjee SD, Dhesy-Thind S. Leong DP, et al. JACC CardioOncol. 2019 Jul 17;1(1):1-10. doi: 10.1016/j.jaccao.2019.06.004. eCollection 2019 Sep. JACC CardioOncol. 2019. PMID: 34396157 Free PMC article.

9

Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis.

Alhussein MM, Mokbel A, Cosman T, Aghel N, Yang EH, Mukherjee SD, Dent S, Ellis PM, Dhesy-Thind S, Leong DP. Alhussein MM, et al. CJC Open. 2021 Jul 14;3(11):1372-1382. doi: 10.1016/j.cjco.2021.06.019. eCollection 2021 Nov. CJC Open. 2021. PMID: 34901806 Free PMC article. Review.

10

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab.

Zhou S, Cirne F, Chow J, Zereshkian A, Bordeleau L, Dhesy-Thind S, Ellis PM, Mukherjee SD, Aghel N, Leong DP. Zhou S, et al. Oncologist. 2023 Sep 7;28(9):e712-e722. doi: 10.1093/oncolo/oyad086. Oncologist. 2023. PMID: 37094996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page